Hims & Hers Health Inc. said an analysis of more than 10,000 patients taking a copycat version of Novo Nordisk A/S’s Ozempic and Wegovy showed the shot was a safe and effective way to shed pounds.

Telehealth companies Hims & Hers Health Inc., Noom Inc. and Sesame Inc. have lured individual customers with low-cost versions of popular weight-loss shots like Ozempic and Wegovy. Now ...

You may have heard about — or maybe even experienced — the short-term side effects of Ozempic® — such as nausea, vomiting, constipation, and diarrhea. But what about its long-term effects?

In a recent study, people with type 2 diabetes who took Ozempic appeared to lower their Alzheimer’s risk more than those using insulin. Ozempic was also linked to a greater reduction in ...

A 24-week trial shows up to 52% decrease in urinary protein and 30% reduction in kidney inflammation among participants. Study: Semaglutide in patients with overweight or obesity and chronic ...

The "About Damn Time" singer shared pics of herself in costume Oct. 26, a month after she brushed off several fans' allegations that she used Ozempic to achieve the slimmer figure she had recently ...

Rybelsus is an oral glucagon-like peptide-1 (GLP-1) agonist and sibling medication to Ozempic and Wegovy. Per a phase 3 trial, Rybelsus was found to reduce cardiovascular risk among patients with ...

People with Type 2 diabetes increasingly turn to weight loss drugs such as Ozempic and Mounjaro, part of a new category of medication called glucagon-like peptide 1, or GLP-1 drugs. Ozempic and ...

Novo Nordisk's blockbuster diabetes drug Ozempic may reduce the risk of developing Alzheimer's disease, according to a new analysis of electronic health records. The findings suggest that Ozempic ...

GLP-1 drugs may target multiple Alzheimer's pathways, including inflammation. Semaglutide (Ozempic) was tied to a reduced risk of Alzheimer's disease diagnoses in people with type 2 diabetes ...